Ascletis Pharma Inc.

Investors

Financials & Filing

2025

2024

2023

2022

2021

2020

2019

2018

Audit Committee - Terms of Reference
2018-12-27
Nomination Committee - Terms of Reference
2018-12-27
List of Directors and Their Role and Function
2018-12-24
Resignation of Non-Executive Director
2018-12-24
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2018
2018-12-03
Announcement - Inside Information
2018-11-20
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2018
2018-11-02
VOLUNTARY ANNOUNCEMENT - PROPOSED AS PRIORITY REVIEW FOR THE NEW DRUG APPLICATION OF RAVIDASVIR BY CHINA FOOD AND DRUG ADMINISTRATION
2018-10-18
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2018
2018-10-03
Voluntary Announcement - Ganovo Enrolled in the Basic Medical Insurance of Tianjin - Capped Reimbursement-Perpatient Pilot Program
2018-09-26

1

© 2018 Ascletis Pharma Inc. All Rights Reserved
浙公网安备 33010802003344号浙ICP备11050387号-1